The health product watchdog has issued a recall of a heartburn medicine amid concerns it contains traces of a cancer-causing chemical.

GlaxoSmithKline is to sell over-the-counter brands in Europe, including Solpadeine, Zantac and Beconase, for €470m to Omega Pharma.